Your browser doesn't support javascript.
loading
Restless legs syndrome in patients with multiple sclerosis: evaluation of risk factors and clinical impact.
Lebrato Hernández, L; Prieto León, M; Cerdá Fuentes, N A; Uclés Sánchez, A J; Casado Chocán, J L; Díaz Sánchez, M.
Afiliación
  • Lebrato Hernández L; Departamento de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Prieto León M; Departamento de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Cerdá Fuentes NA; Departamento de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Uclés Sánchez AJ; Departamento de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Casado Chocán JL; Departamento de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Díaz Sánchez M; Departamento de Neurología, Hospital Universitario Virgen del Rocío, Sevilla, Spain. Electronic address: mariadiazsanchez@hotmail.com.
Neurologia (Engl Ed) ; 37(2): 83-90, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35279227
INTRODUCTION: Restless legs syndrome (RLS) is a disorder characterised by an irresistible urge to move the legs, usually accompanied by unpleasant sensations. It is more frequent in patients with multiple sclerosis (MS) than in the general population. OBJECTIVES: To evaluate the prevalence of RLS, defined according to the 4 essential requirements included in the diagnostic criteria proposed by the International Restless Leg Syndrome Study Group, in a cohort of patients with MS; and to identify potential risk factors and the clinical impact of RLS. RESULTS: The sample included 120 patients with MS, with a mean age of symptom onset of 40 years and an average disease duration of 46 months. The prevalence rate of RLS was 23.3%. MS progression time was significantly shorter in patients with RLS (P=.001). A recent relapse, and symptoms of anxiety, depression, and neuropathic pain were significantly associated with risk of RLS (P=.001, P<.001, P<.001, and P=.001, respectively). In addition, patients with RLS had a greater risk of poor sleep quality, fatigue, daytime sleepiness, and poor quality of life than those without RLS (P=.002, P=.017, P=.013, and P=.009, respectively). CONCLUSIONS: RLS should be considered in the neurological evaluation of patients with MS; early diagnosis and treatment would improve the quality of life of patients with MS presenting RLS.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de las Piernas Inquietas / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: Neurologia (Engl Ed) Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de las Piernas Inquietas / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: Neurologia (Engl Ed) Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: España